Clopidogrel

ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke 4:46
ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke
Thanh Nguyen • 15 Feb 2023
Key data at ISC 2023: DAPT vs IVT, alteplase vs tenecteplase, and EVT in large core stroke 3:43
Key data at ISC 2023: DAPT vs IVT, alteplase vs tenecteplase, and EVT in large core stroke
Thanh Nguyen • 15 Feb 2023
Should DAPT be given to all non-AF ischemic stroke patients? 1:45
Should DAPT be given to all non-AF ischemic stroke patients?
Nijasri Suwanwela • 21 Oct 2022
Key considerations for conducting clinical trials in surgical interventions for ICH 2:45
Key considerations for conducting clinical trials in surgical interventions for ICH
Shahid Nimjee • 25 Oct 2022
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers 1:44
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
S. Claiborne Johnston • 7 Sep 2021
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA 1:48
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA
Ana Catarina Fonseca • 6 Sep 2021
Future applications of precision medicine in stroke treatment 4:16
Future applications of precision medicine in stroke treatment
Ana Catarina Fonseca • 25 Jun 2021
The content of VJNeurology is intended for healthcare professionals